PRADA, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 4.259
AS - Asia 37
SA - Sud America 5
NA - Nord America 1
Totale 4.302
Nazione #
IT - Italia 4.259
CN - Cina 32
BR - Brasile 4
SG - Singapore 4
PY - Paraguay 1
US - Stati Uniti d'America 1
VN - Vietnam 1
Totale 4.302
Città #
Genova 1.707
Genoa 1.640
Rapallo 451
Vado Ligure 448
Beijing 17
Bordighera 13
Ashburn 1
Claro dos Poções 1
Ho Chi Minh City 1
Juiz de Fora 1
Maceió 1
Maricá 1
San Lorenzo 1
Singapore 1
Totale 4.284
Nome #
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 164
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 161
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 157
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 155
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 150
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 142
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 141
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 136
Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? 131
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 131
Sacral Nerve Stimulation for Fecal Incontinence in a Patient with Antiphospholipid Syndrome- Related Autonomic Neuropathy 127
Outcome measures in the clinical evaluation of ambulatory Charcot Marie Tooth 1A subjects 124
Early detection of external neurological symptoms through a wearable smart-glasses prototype 121
Immunohistochemical evidnce of HLA-G expression in extravillous trophoblast invading decidual tissues. 119
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 119
GAIN OR LOSS OF GLYCOSYLATION: THE SWEET SIDE OF MYELIN PROTEIN ZERO 116
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 105
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 102
EARLY ONSET DEMYELINATING CHARCOT‐MARIE‐TOOTH DISEASE CAUSED BY A NOVEL IN‐FRAME ISOLEUCINE DELETION IN PERIPHERAL MYELIN PROTEIN 2 101
Comparison of Strength and Dexterity in Professional and Student Violinists: Setting Foundations to Guide Rehabilitation 95
Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study 93
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 91
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 90
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 88
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 86
Distal motor neuropathy associated with novel EMILIN1 mutation 82
Treadmill training in patients affected by Charcot-Marie-Tooth neuropathy: results of a multicenter, prospective, randomized, single-blind, controlled study 81
People with Charcot-Marie-Tooth disease and COVID-19: Impaired physical conditions due to the lockdown. An International cross-sectional survey 81
NeuroGlasses: A Wearable Prototype for Early Detection of Neurological Symptoms 78
A morphological reappraisal of Tubifex blanchardi Vejdovský, 1891 (Clitellata: Tubificidae) 77
Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease 68
Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years 65
High-dose immunoglobulin pulse therapy and risk of Covid19 infection 63
Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT 61
Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale 59
Maintenance treatment with subcutaneous immunoglobulins in the long-term management of anti-HMCGR myopathy 56
Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature 50
The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical rehabilitation: the value of telerehabilitation for evaluation and continuing treatment 47
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis 45
Objective and subjective evaluation of walking ability with and without the use of a passive brace for hip flexor muscles in individuals with multiple sclerosis 43
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis 38
International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score 37
MaM-36 and abilhand as outcome measures of multiple sclerosis hand disability: An observational study 35
Correction to: Robot‑assisted and traditional intensive rehabilitation therapy in the treatment of post‑acute stroke patient: the experience of a standard rehabilitation ward (Neurological Sciences, (2022), 43, 6, (3999-4001), 10.1007/s10072-022-06041-8) 34
TESTING OVERWORK WEAKNESS IN CHARCOT-MARIE-TOOTH (CMT) DISEASE: IS IT TRUE OR FALSE? 33
Virtual Charcot-Marie-Tooth Examination Score: A Validated Virtual Evaluation for People with Charcot-Marie-Tooth Disease 28
The role of sensory systems in the association between balance and walking in people with multiple sclerosis 28
Circadian rhythms and measures of CNS/autonomic interaction 27
Adaptive Judo and neuropathy: a mini review on motor skills, balance, and quality of life improvement 27
Robot-assisted and traditional intensive rehabilitation therapy in the treatment of post-acute stroke patient: the experience of a standard rehabilitation ward 27
30-Second Chair Stand and 5-Times Sit-to-Stand Tests Are Interesting Tools for Assessing Disability and Ability to Ambulate among Patients with Multiple Sclerosis 26
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 25
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 25
Circadian Rhythms, Sleep, and Aging 24
Basic Pathological Mechanisms in Peripheral Nerve Diseases 10
Measures of CNS-autonomic interaction and responsiveness in disorder of consciousness 5
Totale 4.430
Categoria #
all - tutte 19.081
article - articoli 17.838
book - libri 0
conference - conferenze 1.243
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021306 0 0 0 53 19 23 50 43 28 38 25 27
2021/2022416 16 23 22 34 18 30 20 91 30 54 18 60
2022/2023535 40 54 4 55 87 68 1 54 81 4 72 15
2023/2024305 18 24 7 48 22 66 23 20 19 5 21 32
2024/20251.182 46 105 51 61 140 103 106 210 38 49 129 144
2025/2026611 269 46 156 140 0 0 0 0 0 0 0 0
Totale 4.430